Avian flu: Iraq reports first death - investigates "non-poultry transmissions"
This article was originally published in Clinica
Executive Summary
Iraq has confirmed this week that at least one of three deaths reported in the second half of January that were suspected of being from avian flu was caused by the H5N1 virus. The case is being linked to infection in poultry. The source of the later infection, and death, of the girl's uncle is being investigated, as it appears not to be poultry-related, the World Health Organization is reporting. A third possible avian flu death is also being investigated. Preliminary laboratory confirmation was provided by a US Naval Medical Research Unit, located in Cairo, Egypt, and the UK's collaborating office is currently providing confirmation.
You may also be interested in...
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.